Accolade and Priority Health will discuss how Personalized Healthcare can deliver value for health plans seeking virtual first solutions for whole person care. SEATTLE , June 21, 2022 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD), the company that provides millions of individuals and their families

SEATTLE, June 21, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves over 600 employers and millions of members, today announced that it will release fiscal first quarter 2023 financial results on Thursday, June 30, 2022, after the market closes.

SEATTLE, June 02, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will participate in the following upcoming investor conferences. A webcast and replay of each event will be available at ir.accolade.com.  Wednesday, June 8 at 4:10 pm ET .

Accolade and Headspace Health to increase access to preventative resources and mental health services for adolescents and teens amid national mental health crisis SEATTLE , May 10, 2022 /PRNewswire/ -- Accolade (Nasdaq: ACCD), the company that provides millions of individuals and their families

SEATTLE, May 09, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will participate in the following upcoming investor conferences. A webcast and replay of each event will be available at ir.accolade.com. Thursday, May 12 at 1pm ET .

Medication Integrated Care combines pharmacist-led medication therapy management with advanced analytics powered by Rx Savings Solutions to help employers reach individuals most likely to struggle with prescription complications and barriers to care. SEATTLE , May 3, 2022 /PRNewswire/ -- Accolade

Accolade welcomes executive vice president and chief human resources officer Jennifer Hanson to create an amazing employee experience for the company that partners with human resource leaders to deliver Personalized Healthcare SEATTLE , May 2, 2022 /PRNewswire/ -- Accolade, Inc.  (Nasdaq: ACCD),

Fiscal fourth quarter 2022 revenue of $93.8 million, a 58% increase compared to fiscal fourth quarter 2021 revenue of $59.2 million Fiscal year 2022 revenue of $310.0 million, an 82% increase compared to fiscal year 2021 revenue of $170.4 million SEATTLE, April 28, 2022 (GLOBE NEWSWIRE) --

SEATTLE, April 14, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves over 600 employers and millions of members, today announced that it will release fiscal fourth quarter and full year 2022 financial results on Thursday, April 28, 2022, after the market

New third-party research demonstrates how Accolade enhances employee retention and recruitment, overall experience and satisfaction, and perception of health insurance provider. SEATTLE , March 22, 2022 /PRNewswire/ --  Accolade (Nasdaq: ACCD), the company that provides millions of individuals and